Previous close | 0.4220 |
Open | 0.4170 |
Bid | 0.4270 x N/A |
Ask | 0.4490 x N/A |
Day's range | 0.4170 - 0.4280 |
52-week range | 0.3360 - 6.5800 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 11 Dec 2023 - 15 Dec 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
MIAMI, Dec. 05, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 65th Emerging Growth Conference on December 6th and 7th, 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting
FORT MILL, S.C., January 23, 2023--Ra Medical Systems, Inc. (NYSE American: RMED) (Ra Medical), a medical device and technology company focused on cardiac electrophysiology, announces that four abstracts with clinical data supporting its VIVO technology have been accepted for presentation at the European Heart Rhythm Association Congress (EHRA 2023) being held April 16-18, 2023 in Barcelona. VIVO, developed by Ra Medical’s wholly owned subsidiary Catheter Precision, is a proprietary AI system us
MT. OLIVE, N.J., January 17, 2023--Ra Medical Systems Realigns its Board of Directors.